The effect of freeze/thaw cycles on the stability of compounds in DMSO.
A diverse set of 320 compounds from the Procter & Gamble Pharmaceuticals organic compound repository was prepared as 20-mM DMSO solutions and stored at 4 degrees C under argon in pressurized canisters to simulate a low-humidity environment. The plates were subjected to 25 freeze/thaw cycles while being exposed to ambient atmospheric conditions after each thaw to simulate the time and manner by which compound plates are exposed to the atmosphere during typical liquid-handling and high-throughput screening processes. High-performance liquid chromatography-mass spectrometry with evaporative light-scattering detection was used to quantitate the amount of compound remaining after every 5th freeze/thaw cycle. Control plates were stored either at room temperature under argon or at 4 degrees C under argon without freeze/thaw cycling and were evaluated at the midpoint and the endpoint of the study. The study was conducted over a short time period (i.e., 7 weeks) to minimize the effect of compound degradation over time due to the exposure of the compounds to DMSO. The results from this study will be used to determine the maximum number of freeze/thaw cycles that can be achieved while maintaining acceptable compound integrity.
Kozikowski
Barbara A
BA
Proctor & Gamble Pharmaceuticals, 8700 Mason Montgomery Road, Mason, OH 45040-8006, USA.
Burt
Thomas M
TM
Tirey
Debra A
DA
Williams
Lisa E
LE
Kuzmak
Barbara R
BR
Stanton
David T
DT
Morand
Kenneth L
KL
Nelson
Sandra L
SL
D001128:Argon; D002851:Chromatography, High Pressure Liquid; D004121:Dimethyl Sulfoxide / Q000737:chemistry / Q000378:metabolism*; D004355:Drug Stability; D004356:Drug Storage; D005615:Freezing; D004364:Pharmaceutical Preparations / Q000737:chemistry / Q000378:metabolism*; D012997:Solvents / Q000737:chemistry / Q000378:metabolism*
D004364:Pharmaceutical Preparations; D012997:Solvents; D001128:Argon; D004121:Dimethyl Sulfoxide